Global Warfarin Market Growth 2020-2025


Sep, 2020 | Report ID: 147238 | 167 | Pharmaceuticals and Healthcare

According to this study, over the next five years the Warfarin market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Warfarin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Warfarin market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Warfarin, covering the supply chain analysis, impact assessment to the Warfarin market size growth rate in several scenarios, and the measures to be undertaken by Warfarin companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

1mg/Tablet

2.5mg/Tablet

3mg/Tablet

5mg/Tablet

Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Mechanical Heart Valves (MHV) Replacement

Atrial Fibrillation (AF)

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Qilu Pharma

BRISTOL MYERS SQUIBB

Sine Pharma (Shanghai Pharma)

Henan Zhongjie Pharma

Shanghai Xudong Haipu Pharmaceutical (SunRise)

Beijing Jialin Pharmaceutical

Cipla (InvaGen)

Amneal Pharma

Orion Corporation Orion Pharma

TEVA (Barr, PLIVA)

UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)

IPCA LABS LTD

Taro Pharmaceutical Industries Ltd.

Zydus Pharmaceuticals (USA) Inc

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Warfarin consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Warfarin market by identifying its various subsegments.

Focuses on the key global Warfarin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Warfarin with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Warfarin submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Warfarin Consumption 2015-2025

2.1.2 Warfarin Consumption CAGR by Region

2.2 Warfarin Segment by Type

2.2.1 1mg/Tablet

2.2.2 2.5mg/Tablet

2.2.3 3mg/Tablet

2.2.4 5mg/Tablet

2.2.5 Others

2.3 Warfarin Consumption by Type

2.3.1 Global Warfarin Consumption Market Share by Type (2015-2020)

2.3.2 Global Warfarin Revenue and Market Share by Type (2015-2020)

2.3.3 Global Warfarin Sale Price by Type (2015-2020)

2.4 Warfarin Segment by Application

2.4.1 Mechanical Heart Valves (MHV) Replacement

2.4.2 Atrial Fibrillation (AF)

2.4.3 Deep Vein Thrombosis (DVT)

2.4.4 Pulmonary Embolism (PE)

2.4.5 Others

2.5 Warfarin Consumption by Application

2.5.1 Global Warfarin Consumption Market Share by Type (2015-2020)

2.5.2 Global Warfarin Value and Market Share by Type (2015-2020)

2.5.3 Global Warfarin Sale Price by Type (2015-2020)

3 Global Warfarin by Company

3.1 Global Warfarin Sales Market Share by Company

3.1.1 Global Warfarin Sales by Company (2018-2020)

3.1.2 Global Warfarin Sales Market Share by Company (2018-2020)

3.2 Global Warfarin Revenue Market Share by Company

3.2.1 Global Warfarin Revenue by Company (2018-2020)

3.2.2 Global Warfarin Revenue Market Share by Company (2018-2020)

3.3 Global Warfarin Sale Price by Company

3.4 Global Warfarin Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Warfarin Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Warfarin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Warfarin by Regions

4.1 Warfarin by Regions

4.2 Americas Warfarin Consumption Growth

4.3 APAC Warfarin Consumption Growth

4.4 Europe Warfarin Consumption Growth

4.5 Middle East & Africa Warfarin Consumption Growth

5 Americas

5.1 Americas Warfarin Consumption by Countries

5.1.1 Americas Warfarin Consumption by Countries (2015-2020)

5.1.2 Americas Warfarin Value by Countries (2015-2020)

5.2 Americas Warfarin Consumption by Type

5.3 Americas Warfarin Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Warfarin Consumption by Regions

6.1.1 APAC Warfarin Consumption by Regions (2015-2020)

6.1.2 APAC Warfarin Value by Regions (2015-2020)

6.2 APAC Warfarin Consumption by Type

6.3 APAC Warfarin Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Warfarin by Countries

7.1.1 Europe Warfarin Consumption by Countries (2015-2020)

7.1.2 Europe Warfarin Value by Countries (2015-2020)

7.2 Europe Warfarin Consumption by Type

7.3 Europe Warfarin Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Warfarin by Countries

8.1.1 Middle East & Africa Warfarin Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Warfarin Value by Countries (2015-2020)

8.2 Middle East & Africa Warfarin Consumption by Type

8.3 Middle East & Africa Warfarin Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Warfarin Distributors

10.3 Warfarin Customer

11 Global Warfarin Market Forecast

11.1 Global Warfarin Consumption Forecast (2021-2025)

11.2 Global Warfarin Forecast by Regions

11.2.1 Global Warfarin Forecast by Regions (2021-2025)

11.2.2 Global Warfarin Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Warfarin Forecast by Type

11.8 Global Warfarin Forecast by Application

12 Key Players Analysis

12.1 Qilu Pharma

12.1.1 Company Information

12.1.2 Warfarin Product Offered

12.1.3 Qilu Pharma Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Qilu Pharma Latest Developments

12.2 BRISTOL MYERS SQUIBB

12.2.1 Company Information

12.2.2 Warfarin Product Offered

12.2.3 BRISTOL MYERS SQUIBB Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 BRISTOL MYERS SQUIBB Latest Developments

12.3 Sine Pharma (Shanghai Pharma)

12.3.1 Company Information

12.3.2 Warfarin Product Offered

12.3.3 Sine Pharma (Shanghai Pharma) Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Sine Pharma (Shanghai Pharma) Latest Developments

12.4 Henan Zhongjie Pharma

12.4.1 Company Information

12.4.2 Warfarin Product Offered

12.4.3 Henan Zhongjie Pharma Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Henan Zhongjie Pharma Latest Developments

12.5 Shanghai Xudong Haipu Pharmaceutical (SunRise)

12.5.1 Company Information

12.5.2 Warfarin Product Offered

12.5.3 Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Shanghai Xudong Haipu Pharmaceutical (SunRise) Latest Developments

12.6 Beijing Jialin Pharmaceutical

12.6.1 Company Information

12.6.2 Warfarin Product Offered

12.6.3 Beijing Jialin Pharmaceutical Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Beijing Jialin Pharmaceutical Latest Developments

12.7 Cipla (InvaGen)

12.7.1 Company Information

12.7.2 Warfarin Product Offered

12.7.3 Cipla (InvaGen) Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Cipla (InvaGen) Latest Developments

12.8 Amneal Pharma

12.8.1 Company Information

12.8.2 Warfarin Product Offered

12.8.3 Amneal Pharma Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Amneal Pharma Latest Developments

12.9 Orion Corporation Orion Pharma

12.9.1 Company Information

12.9.2 Warfarin Product Offered

12.9.3 Orion Corporation Orion Pharma Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Orion Corporation Orion Pharma Latest Developments

12.10 TEVA (Barr, PLIVA)

12.10.1 Company Information

12.10.2 Warfarin Product Offered

12.10.3 TEVA (Barr, PLIVA) Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 TEVA (Barr, PLIVA) Latest Developments

12.11 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)

12.11.1 Company Information

12.11.2 Warfarin Product Offered

12.11.3 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Latest Developments

12.12 IPCA LABS LTD

12.12.1 Company Information

12.12.2 Warfarin Product Offered

12.12.3 IPCA LABS LTD Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 IPCA LABS LTD Latest Developments

12.13 Taro Pharmaceutical Industries Ltd.

12.13.1 Company Information

12.13.2 Warfarin Product Offered

12.13.3 Taro Pharmaceutical Industries Ltd. Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Taro Pharmaceutical Industries Ltd. Latest Developments

12.14 Zydus Pharmaceuticals (USA) Inc

12.14.1 Company Information

12.14.2 Warfarin Product Offered

12.14.3 Zydus Pharmaceuticals (USA) Inc Warfarin Sales, Revenue, Price and Gross Margin (2018-2020)

12.14.4 Main Business Overview

12.14.5 Zydus Pharmaceuticals (USA) Inc Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Warfarin Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of 1mg/Tablet

Table 5. Major Players of 2.5mg/Tablet

Table 6. Major Players of 3mg/Tablet

Table 7. Major Players of 5mg/Tablet

Table 8. Major Players of Others

Table 9. Global Consumption Sales by Type (2015-2020)

Table 10. Global Warfarin Consumption Market Share by Type (2015-2020)

Table 11. Global Warfarin Revenue by Type (2015-2020) ($ million)

Table 12. Global Warfarin Value Market Share by Type (2015-2020) ($ Millions)

Table 13. Global Warfarin Sale Price by Type (2015-2020)

Table 14. Global Consumption Sales by Application (2015-2020)

Table 15. Global Warfarin Consumption Market Share by Application (2015-2020)

Table 16. Global Warfarin Value by Application (2015-2020)

Table 17. Global Warfarin Value Market Share by Application (2015-2020)

Table 18. Global Warfarin Sale Price by Application (2015-2020)

Table 19. Global Warfarin Sales by Company (2017-2019) (KG)

Table 20. Global Warfarin Sales Market Share by Company (2017-2019)

Table 21. Global Warfarin Revenue by Company (2017-2019) ($ Millions)

Table 22. Global Warfarin Revenue Market Share by Company (2017-2019)

Table 23. Global Warfarin Sale Price by Company (2017-2019)

Table 24. Global Warfarin Manufacturing Base Distribution and Sales Area by Manufacturers

Table 25. Players Warfarin Products Offered

Table 26. Warfarin Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 27. Global Warfarin Consumption by Regions 2015-2020 (KG)

Table 28. Global Warfarin Consumption Market Share by Regions 2015-2020

Table 29. Global Warfarin Value by Regions 2015-2020 ($ Millions)

Table 30. Global Warfarin Value Market Share by Regions 2015-2020

Table 31. Americas Warfarin Consumption by Countries (2015-2020) (KG)

Table 32. Americas Warfarin Consumption Market Share by Countries (2015-2020)

Table 33. Americas Warfarin Value by Countries (2015-2020) ($ Millions)

Table 34. Americas Warfarin Value Market Share by Countries (2015-2020)

Table 35. Americas Warfarin Consumption by Type (2015-2020) (KG)

Table 36. Americas Warfarin Consumption Market Share by Type (2015-2020)

Table 37. Americas Warfarin Consumption by Application (2015-2020) (KG)

Table 38. Americas Warfarin Consumption Market Share by Application (2015-2020)

Table 39. APAC Warfarin Consumption by Countries (2015-2020) (KG)

Table 40. APAC Warfarin Consumption Market Share by Countries (2015-2020)

Table 41. APAC Warfarin Value by Regions (2015-2020) ($ Millions)

Table 42. APAC Warfarin Value Market Share by Regions (2015-2020)

Table 43. APAC Warfarin Consumption by Type (2015-2020) (KG)

Table 44. APAC Warfarin Consumption Market Share by Type (2015-2020)

Table 45. APAC Warfarin Consumption by Application (2015-2020) (KG)

Table 46. APAC Warfarin Consumption Market Share by Application (2015-2020)

Table 47. Europe Warfarin Consumption by Countries (2015-2020) (KG)

Table 48. Europe Warfarin Consumption Market Share by Countries (2015-2020)

Table 49. Europe Warfarin Value by Countries (2015-2020) ($ Millions)

Table 50. Europe Warfarin Value Market Share by Countries (2015-2020)

Table 51. Europe Warfarin Consumption by Type (2015-2020) (KG)

Table 52. Europe Warfarin Consumption Market Share by Type (2015-2020)

Table 53. Europe Warfarin Consumption by Application (2015-2020) (KG)

Table 54. Europe Warfarin Consumption Market Share by Application (2015-2020)

Table 55. Middle East & Africa Warfarin Consumption by Countries (2015-2020) (KG)

Table 56. Middle East & Africa Warfarin Consumption Market Share by Countries (2015-2020)

Table 57. Middle East & Africa Warfarin Value by Countries (2015-2020) ($ Millions)

Table 58. Middle East & Africa Warfarin Value Market Share by Countries (2015-2020)

Table 59. Middle East & Africa Warfarin Consumption by Type (2015-2020) (KG)

Table 60. Middle East & Africa Warfarin Consumption Market Share by Type (2015-2020)

Table 61. Middle East & Africa Warfarin Consumption by Application (2015-2020) (KG)

Table 62. Middle East & Africa Warfarin Consumption Market Share by Application (2015-2020)

Table 63. Warfarin Distributors List

Table 64. Warfarin Customer List

Table 65. Global Warfarin Consumption Forecast by Countries (2021-2025) (KG)

Table 66. Global Warfarin Consumption Market Forecast by Regions

Table 67. Global Warfarin Value Forecast by Countries (2021-2025) ($ Millions)

Table 68. Global Warfarin Value Market Share Forecast by Regions

Table 69. Global Warfarin Consumption Forecast by Type (2021-2025) (KG)

Table 70. Global Warfarin Consumption Market Share Forecast by Type (2021-2025)

Table 71. Global Warfarin Value Forecast by Type (2021-2025) ($ Millions)

Table 72. Global Warfarin Value Market Share Forecast by Type (2021-2025)

Table 73. Global Warfarin Consumption Forecast by Application (2021-2025) (KG)

Table 74. Global Warfarin Consumption Market Share Forecast by Application (2021-2025)

Table 75. Global Warfarin Value Forecast by Application (2021-2025) ($ Millions)

Table 76. Global Warfarin Value Market Share Forecast by Application (2021-2025)

Table 77. Qilu Pharma Product Offered

Table 78. Qilu Pharma Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 79. Qilu Pharma Main Business

Table 80. Qilu Pharma Latest Developments

Table 81. Qilu Pharma Basic Information, Company Total Revenue (in $ million), Warfarin Manufacturing Base, Sales Area and Its Competitors

Table 82. BRISTOL MYERS SQUIBB Product Offered

Table 83. BRISTOL MYERS SQUIBB Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 84. BRISTOL MYERS SQUIBB Main Business

Table 85. BRISTOL MYERS SQUIBB Latest Developments

Table 86. BRISTOL MYERS SQUIBB Basic Information, Company Total Revenue (in $ million), Warfarin Manufacturing Base, Sales Area and Its Competitors

Table 87. Sine Pharma (Shanghai Pharma) Product Offered

Table 88. Sine Pharma (Shanghai Pharma) Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 89. Sine Pharma (Shanghai Pharma) Main Business

Table 90. Sine Pharma (Shanghai Pharma) Latest Developments

Table 91. Sine Pharma (Shanghai Pharma) Basic Information, Company Total Revenue (in $ million), Warfarin Manufacturing Base, Sales Area and Its Competitors

Table 92. Henan Zhongjie Pharma Product Offered

Table 93. Henan Zhongjie Pharma Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 94. Henan Zhongjie Pharma Main Business

Table 95. Henan Zhongjie Pharma Latest Developments

Table 96. Henan Zhongjie Pharma Basic Information, Company Total Revenue (in $ million), Warfarin Manufacturing Base, Sales Area and Its Competitors

Table 97. Shanghai Xudong Haipu Pharmaceutical (SunRise) Product Offered

Table 98. Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 99. Shanghai Xudong Haipu Pharmaceutical (SunRise) Main Business

Table 100. Shanghai Xudong Haipu Pharmaceutical (SunRise) Latest Developments

Table 101. Shanghai Xudong Haipu Pharmaceutical (SunRise) Basic Information, Company Total Revenue (in $ million), Warfarin Manufacturing Base, Sales Area and Its Competitors

Table 102. Beijing Jialin Pharmaceutical Product Offered

Table 103. Beijing Jialin Pharmaceutical Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 104. Beijing Jialin Pharmaceutical Main Business

Table 105. Beijing Jialin Pharmaceutical Latest Developments

Table 106. Beijing Jialin Pharmaceutical Basic Information, Company Total Revenue (in $ million), Warfarin Manufacturing Base, Sales Area and Its Competitors

Table 107. Cipla (InvaGen) Product Offered

Table 108. Cipla (InvaGen) Basic Information, Company Total Revenue (in $ million), Warfarin Manufacturing Base, Sales Area and Its Competitors

Table 109. Cipla (InvaGen) Main Business

Table 110. Cipla (InvaGen) Latest Developments

Table 111. Cipla (InvaGen) Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 112. Amneal Pharma Product Offered

Table 113. Amneal Pharma Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 114. Amneal Pharma Main Business

Table 115. Amneal Pharma Latest Developments

Table 116. Amneal Pharma Basic Information, Company Total Revenue (in $ million), Warfarin Manufacturing Base, Sales Area and Its Competitors

Table 117. Orion Corporation Orion Pharma Product Offered

Table 118. Orion Corporation Orion Pharma Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 119. Orion Corporation Orion Pharma Main Business

Table 120. Orion Corporation Orion Pharma Latest Developments

Table 121. Orion Corporation Orion Pharma Basic Information, Company Total Revenue (in $ million), Warfarin Manufacturing Base, Sales Area and Its Competitors

Table 122. TEVA (Barr, PLIVA) Product Offered

Table 123. TEVA (Barr, PLIVA) Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 124. TEVA (Barr, PLIVA) Main Business

Table 125. TEVA (Barr, PLIVA) Latest Developments

Table 126. TEVA (Barr, PLIVA) Basic Information, Company Total Revenue (in $ million), Warfarin Manufacturing Base, Sales Area and Its Competitors

Table 127. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Product Offered

Table 128. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 129. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Main Business

Table 130. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 131. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Latest Developments

Table 132. IPCA LABS LTD Product Offered

Table 133. IPCA LABS LTD Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 134. IPCA LABS LTD Main Business

Table 135. IPCA LABS LTD Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 136. IPCA LABS LTD Latest Developments

Table 137. Taro Pharmaceutical Industries Ltd. Product Offered

Table 138. Taro Pharmaceutical Industries Ltd. Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 139. Taro Pharmaceutical Industries Ltd. Main Business

Table 140. Taro Pharmaceutical Industries Ltd. Latest Developments

Table 141. Taro Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 142. Zydus Pharmaceuticals (USA) Inc Product Offered

Table 143. Zydus Pharmaceuticals (USA) Inc Warfarin Sales (KG), Revenue ($ Million), Price (USD/G) and Gross Margin (2018-2020E)

Table 144. Zydus Pharmaceuticals (USA) Inc Main Business

Table 145. Zydus Pharmaceuticals (USA) Inc Latest Developments

Table 146. Zydus Pharmaceuticals (USA) Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Warfarin

Figure 2. Warfarin Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Warfarin Consumption Growth Rate 2015-2025 (KG)

Figure 5. Global Warfarin Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of 1mg/Tablet

Figure 7. Product Picture of 2.5mg/Tablet

Figure 8. Product Picture of 3mg/Tablet

Figure 9. Product Picture of 5mg/Tablet

Figure 10. Product Picture of Others

Figure 11. Global Warfarin Consumption Market Share by Type (2015-2020)

Figure 12. Global Warfarin Value Market Share by Type (2015-2020)

Figure 13. Warfarin Consumed in Mechanical Heart Valves (MHV) Replacement

Figure 14. Global Warfarin Market: Mechanical Heart Valves (MHV) Replacement (2015-2020) (KG)

Figure 15. Global Warfarin Market: Mechanical Heart Valves (MHV) Replacement (2015-2020) ($ Millions)

Figure 16. Warfarin Consumed in Atrial Fibrillation (AF)

Figure 17. Global Warfarin Market: Atrial Fibrillation (AF) (2015-2020) (KG)

Figure 18. Global Warfarin Market: Atrial Fibrillation (AF) (2015-2020) ($ Millions)

Figure 19. Warfarin Consumed in Deep Vein Thrombosis (DVT)

Figure 20. Global Warfarin Market: Deep Vein Thrombosis (DVT) (2015-2020) (KG)

Figure 21. Global Warfarin Market: Deep Vein Thrombosis (DVT) (2015-2020) ($ Millions)

Figure 22. Warfarin Consumed in Pulmonary Embolism (PE)

Figure 23. Global Warfarin Market: Pulmonary Embolism (PE) (2015-2020) (KG)

Figure 24. Global Warfarin Market: Pulmonary Embolism (PE) (2015-2020) ($ Millions)

Figure 25. Warfarin Consumed in Others

Figure 26. Global Warfarin Market: Others (2015-2020) (KG)

Figure 27. Global Warfarin Market: Others (2015-2020) ($ Millions)

Figure 28. Global Warfarin Consumption Market Share by Application (2015-2020)

Figure 29. Global Warfarin Value Market Share by Application (2015-2020)

Figure 30. Global Warfarin Sales Market Share by Company in 2017

Figure 31. Global Warfarin Sales Market Share by Company in 2019

Figure 32. Global Warfarin Revenue Market Share by Company in 2017

Figure 33. Global Warfarin Revenue Market Share by Company in 2019

Figure 34. Global Warfarin Sale Price by Company in 2019

Figure 35. Global Warfarin Consumption Market Share by Regions 2015-2020

Figure 36. Global Warfarin Value Market Share by Regions 2015-2020

Figure 37. Americas Warfarin Consumption 2015-2020 (KG)

Figure 38. Americas Warfarin Value 2015-2020 ($ Millions)

Figure 39. APAC Warfarin Consumption 2015-2020 (KG)

Figure 40. APAC Warfarin Value 2015-2020 ($ Millions)

Figure 41. Europe Warfarin Consumption 2015-2020 (KG)

Figure 42. Europe Warfarin Value 2015-2020 ($ Millions)

Figure 43. Middle East & Africa Warfarin Consumption 2015-2020 (KG)

Figure 44. Middle East & Africa Warfarin Value 2015-2020 ($ Millions)

Figure 45. Americas Warfarin Consumption Market Share by Countries in 2019

Figure 46. Americas Warfarin Value Market Share by Countries in 2019

Figure 47. Americas Warfarin Consumption Market Share by Type in 2019

Figure 48. Americas Warfarin Consumption Market Share by Application in 2019

Figure 49. United States Warfarin Consumption Growth 2015-2020 (KG)

Figure 50. United States Warfarin Value Growth 2015-2020 ($ Millions)

Figure 51. Canada Warfarin Consumption Growth 2015-2020 (KG)

Figure 52. Canada Warfarin Value Growth 2015-2020 ($ Millions)

Figure 53. Mexico Warfarin Consumption Growth 2015-2020 (KG)

Figure 54. Mexico Warfarin Value Growth 2015-2020 ($ Millions)

Figure 55. APAC Warfarin Consumption Market Share by Countries in 2019

Figure 56. APAC Warfarin Value Market Share by Regions in 2019

Figure 57. APAC Warfarin Consumption Market Share by Type in 2019

Figure 58. APAC Warfarin Consumption Market Share by Application in 2019

Figure 59. China Warfarin Consumption Growth 2015-2020 (KG)

Figure 60. China Warfarin Value Growth 2015-2020 ($ Millions)

Figure 61. Japan Warfarin Consumption Growth 2015-2020 (KG)

Figure 62. Japan Warfarin Value Growth 2015-2020 ($ Millions)

Figure 63. Korea Warfarin Consumption Growth 2015-2020 (KG)

Figure 64. Korea Warfarin Value Growth 2015-2020 ($ Millions)

Figure 65. Southeast Asia Warfarin Consumption Growth 2015-2020 (KG)

Figure 66. Southeast Asia Warfarin Value Growth 2015-2020 ($ Millions)

Figure 67. India Warfarin Consumption Growth 2015-2020 (KG)

Figure 68. India Warfarin Value Growth 2015-2020 ($ Millions)

Figure 69. Australia Warfarin Consumption Growth 2015-2020 (KG)

Figure 70. Australia Warfarin Value Growth 2015-2020 ($ Millions)

Figure 71. Europe Warfarin Consumption Market Share by Countries in 2019

Figure 72. Europe Warfarin Value Market Share by Countries in 2019

Figure 73. Europe Warfarin Consumption Market Share by Type in 2019

Figure 74. Europe Warfarin Consumption Market Share by Application in 2019

Figure 75. Germany Warfarin Consumption Growth 2015-2020 (KG)

Figure 76. Germany Warfarin Value Growth 2015-2020 ($ Millions)

Figure 77. France Warfarin Consumption Growth 2015-2020 (KG)

Figure 78. France Warfarin Value Growth 2015-2020 ($ Millions)

Figure 79. UK Warfarin Consumption Growth 2015-2020 (KG)

Figure 80. UK Warfarin Value Growth 2015-2020 ($ Millions)

Figure 81. Italy Warfarin Consumption Growth 2015-2020 (KG)

Figure 82. Italy Warfarin Value Growth 2015-2020 ($ Millions)

Figure 83. Russia Warfarin Consumption Growth 2015-2020 (KG)

Figure 84. Russia Warfarin Value Growth 2015-2020 ($ Millions)

Figure 85. Middle East & Africa Warfarin Consumption Market Share by Countries in 2019

Figure 86. Middle East & Africa Warfarin Value Market Share by Countries in 2019

Figure 87. Middle East & Africa Warfarin Consumption Market Share by Type in 2019

Figure 88. Middle East & Africa Warfarin Consumption Market Share by Application in 2019

Figure 89. Egypt Warfarin Consumption Growth 2015-2020 (KG)

Figure 90. Egypt Warfarin Value Growth 2015-2020 ($ Millions)

Figure 91. South Africa Warfarin Consumption Growth 2015-2020 (KG)

Figure 92. South Africa Warfarin Value Growth 2015-2020 ($ Millions)

Figure 93. Israel Warfarin Consumption Growth 2015-2020 (KG)

Figure 94. Israel Warfarin Value Growth 2015-2020 ($ Millions)

Figure 95. Turkey Warfarin Consumption Growth 2015-2020 (KG)

Figure 96. Turkey Warfarin Value Growth 2015-2020 ($ Millions)

Figure 97. GCC Countries Warfarin Consumption Growth 2015-2020 (KG)

Figure 98. GCC Countries Warfarin Value Growth 2015-2020 ($ Millions)

Figure 99. Global Warfarin Consumption Growth Rate Forecast (2021-2025) (KG)

Figure 100. Global Warfarin Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 101. Americas Warfarin Consumption 2021-2025 (KG)

Figure 102. Americas Warfarin Value 2021-2025 ($ Millions)

Figure 103. APAC Warfarin Consumption 2021-2025 (KG)

Figure 104. APAC Warfarin Value 2021-2025 ($ Millions)

Figure 105. Europe Warfarin Consumption 2021-2025 (KG)

Figure 106. Europe Warfarin Value 2021-2025 ($ Millions)

Figure 107. Middle East & Africa Warfarin Consumption 2021-2025 (KG)

Figure 108. Middle East & Africa Warfarin Value 2021-2025 ($ Millions)

Figure 109. United States Warfarin Consumption 2021-2025 (KG)

Figure 110. United States Warfarin Value 2021-2025 ($ Millions)

Figure 111. Canada Warfarin Consumption 2021-2025 (KG)

Figure 112. Canada Warfarin Value 2021-2025 ($ Millions)

Figure 113. Mexico Warfarin Consumption 2021-2025 (KG)

Figure 114. Mexico Warfarin Value 2021-2025 ($ Millions)

Figure 115. Brazil Warfarin Consumption 2021-2025 (KG)

Figure 116. Brazil Warfarin Value 2021-2025 ($ Millions)

Figure 117. China Warfarin Consumption 2021-2025 (KG)

Figure 118. China Warfarin Value 2021-2025 ($ Millions)

Figure 119. Japan Warfarin Consumption 2021-2025 (KG)

Figure 120. Japan Warfarin Value 2021-2025 ($ Millions)

Figure 121. Korea Warfarin Consumption 2021-2025 (KG)

Figure 122. Korea Warfarin Value 2021-2025 ($ Millions)

Figure 123. Southeast Asia Warfarin Consumption 2021-2025 (KG)

Figure 124. Southeast Asia Warfarin Value 2021-2025 ($ Millions)

Figure 125. India Warfarin Consumption 2021-2025 (KG)

Figure 126. India Warfarin Value 2021-2025 ($ Millions)

Figure 127. Australia Warfarin Consumption 2021-2025 (KG)

Figure 128. Australia Warfarin Value 2021-2025 ($ Millions)

Figure 129. Germany Warfarin Consumption 2021-2025 (KG)

Figure 130. Germany Warfarin Value 2021-2025 ($ Millions)

Figure 131. France Warfarin Consumption 2021-2025 (KG)

Figure 132. France Warfarin Value 2021-2025 ($ Millions)

Figure 133. UK Warfarin Consumption 2021-2025 (KG)

Figure 134. UK Warfarin Value 2021-2025 ($ Millions)

Figure 135. Italy Warfarin Consumption 2021-2025 (KG)

Figure 136. Italy Warfarin Value 2021-2025 ($ Millions)

Figure 137. Russia Warfarin Consumption 2021-2025 (KG)

Figure 138. Russia Warfarin Value 2021-2025 ($ Millions)

Figure 139. Spain Warfarin Consumption 2021-2025 (KG)

Figure 140. Spain Warfarin Value 2021-2025 ($ Millions)

Figure 141. Egypt Warfarin Consumption 2021-2025 (KG)

Figure 142. Egypt Warfarin Value 2021-2025 ($ Millions)

Figure 143. South Africa Warfarin Consumption 2021-2025 (KG)

Figure 144. South Africa Warfarin Value 2021-2025 ($ Millions)

Figure 145. Israel Warfarin Consumption 2021-2025 (KG)

Figure 146. Israel Warfarin Value 2021-2025 ($ Millions)

Figure 147. Turkey Warfarin Consumption 2021-2025 (KG)

Figure 148. Turkey Warfarin Value 2021-2025 ($ Millions)

Figure 149. GCC Countries Warfarin Consumption 2021-2025 (KG)

Figure 150. GCC Countries Warfarin Value 2021-2025 ($ Millions)

Figure 151. Qilu Pharma Warfarin Market Share (2018-2020)

Figure 152. BRISTOL MYERS SQUIBB Warfarin Market Share (2018-2020)

Figure 153. Sine Pharma (Shanghai Pharma) Warfarin Market Share (2018-2020)

Figure 154. Henan Zhongjie Pharma Warfarin Market Share (2018-2020)

Figure 155. Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Market Share (2018-2020)

Figure 156. Beijing Jialin Pharmaceutical Warfarin Market Share (2018-2020)

Figure 157. Cipla (InvaGen) Warfarin Market Share (2018-2020)

Figure 158. Amneal Pharma Warfarin Market Share (2018-2020)

Figure 159. Orion Corporation Orion Pharma Warfarin Market Share (2018-2020)

Figure 160. TEVA (Barr, PLIVA) Warfarin Market Share (2018-2020)

Figure 161. UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Market Share (2018-2020)

Figure 162. IPCA LABS LTD Warfarin Market Share (2018-2020)

Figure 163. Taro Pharmaceutical Industries Ltd. Warfarin Market Share (2018-2020)

Figure 164. Zydus Pharmaceuticals (USA) Inc Warfarin Market Share (2018-2020)

Sample Request is not available